Cylera secured $10M in Series A Funding

Cylera, a New York-based healthcare cybersecurity and intelligence company, has now secured $10 million in a Series A funding round.

Cylera is founded by the Timur Ozekcin. It provides a centralized cybersecurity solution that secures the entire connected environment for risk analysis, asset management, and threat detection.

Executive Opinion

“Over the past year there has been a further acceleration of the digitalization and adoption of IoT devices across hospitals, pharmaceutical companies, biotech, life sciences and manufacturing, which can decrease operational risk and increase efficiencies,” said Timur Ozekcin, Co-founder and CEO of Cylera. “However, with this expanded footprint and reliance on connected devices, organizations are experiencing attacks targeted at connected medical devices, operational technology and IoT devices to extort money, impact patient care and disrupt operations. With our latest round of funding, Cylera is fueling the next phase of innovation to safeguard organizations against cyberattacks on connected devices.”

“Cylera is one of the most exciting companies within the fast-growing HIoT sector. With its proven, ground-breaking technology already being used by some of the largest healthcare organizations and hospitals globally, it is well-positioned as a market leader in the space,” said Taylor Whitman, Managing Director at Concord Health Partners, LLC. “We are proud to continue on this journey with Cylera to have a direct impact on patient safety and help enable the technology globally.”

Cylera latest funding

The round which brought the total funding to $17 million, was backed by the Maverick Venture and Concord Health Partners with participation from the Contour Venture Partners, Concord Health Partners, Greak Oaks Venture Capital, Dreamit Ventures, Red Bear Angels and Samsung NEXT.

The company as of now has plans to use the new funds to expand its presence into the new global markets via strategic channel partners, to double the headcount across the research and development, customer success, extend the technology into the new verticals, channel support, sales, and marketing over the next six months.

Leave a Reply

Your email address will not be published.